Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
783 studies found for:    Cetuximab
Show Display Options
Rank Status Study
1 Completed Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer
Condition: Recurrent Head and Neck Cancer
Intervention: Drug: IPI-926 and Cetuximab
2 Completed Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Cetuximab
3 Not yet recruiting Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate
Conditions: Head and Neck Squamous Cell Carcinoma;   Margin Assessment
Intervention: Drug: Cetuximab-IRDye800CW
4 Recruiting Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Condition: Head and Neck Cancer
Intervention: Drug: Cetuximab-IRDye800
5 Terminated An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Carcinoma, Squamous Cell
Intervention: Drug: Cetuximab
6 Recruiting Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Dose escalation cetuximab;   Drug: Standard dose cetuximab
7 Completed Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Cetuximab
8 Completed FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer
Condition: Esophageal Cancer Stage III
Intervention: Drug: radiochemotherapy,combination Cetuximab-FOLFOX
9 Completed Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients
Condition: Stage IV Cancer
Intervention: Drug: Cetuximab-Zr. 89
10 Recruiting Cetuximab Rechallenge Study
Condition: Metastatic Colorectal Cancer
Intervention: Drug: cetuximab-containing chemotherapy
11 Completed
Has Results
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Biological: Cetuximab + concomitant boost radiotherapy
12 Active, not recruiting Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects
Conditions: Colorectal Cancer Metastatic;   C-met Overexpression
Intervention: Drug: Tivantinib (ARQ197)
13 Completed
Has Results
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
Condition: Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Cetuximab
14 Recruiting Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy
Condition: Adenoid Cystic Carcinoma
Intervention: Drug: Cetuximab
15 Recruiting Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss
Condition: Carcinoma, Squamous Cell of Head and Neck
Interventions: Drug: Copanlisib;   Drug: Cetuximab
16 Completed Lapatinib and Cetuximab in Patients With Solid Tumors
Conditions: Colorectal Cancer;   Lung Cancer;   Head and Neck Cancer
Intervention: Drug: cetuximab and lapatinib
17 Active, not recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Conditions: Thymoma;   Thymic Carcinoma;   Clinical Masaoka Stage II to IVA
Intervention: Drug: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
18 Completed Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR
Conditions: Skin Diseases;   Carcinoma, Squamous Cell
Intervention: Drug: cetuximab
19 Completed Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
Condition: Colorectal Cancer Metastatic
Intervention: Drug: Cetuximab
20 Completed A Phase 2a/2b Multicenter, Open-Label Study to Evaluate NKTR 102 in Combination With Cetuximab Versus Irinotecan in Combination With Cetuximab in Second Line Colorectal Cancer Patients
Conditions: Tumor;   Colorectal Cancer
Intervention: Drug: NKTR-102 + Cetuximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.